PAK3 mutation in nonsyndromic X-linked mental retardation
Kristina M. Allen(NKT Therapeutics (United States)), Christopher A. Walsh(Boston Children's Hospital), Shubha Bagrodia(Scripps Research Institute), M. W. Partington(University of King's College), John C. Mulley(The University of Adelaide), Richard A. Cerione(Cornell University), John MacMillan(Royal Children's Hospital), Joseph G. Gleeson(Children’s Institute)
Cited by 472
Related Papers
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci
|Neuron|2015|1.5k
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait
|The American Journal of Human Genetics|2002|1.3k
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
|Nature Genetics|2012|696